Product

Sartorius STR200L Single-Use Bioreactor

Sartorius STR200L Single-Use Bioreactor

The Sartorius STR200L is a modular single-use bioreactor from the BIOSTAT® STR series, specifically designed for 200L-scale pilot and commercial production. Utilizing stirred-tank technology with Flexsafe® STR bags, it supports mammalian (e.g., CHO), insect cell, and microcarrier cultures, widely applied in mAb, vaccine, and gene therapy (e.g., AAV vector) manufacturing.

Price:Negotiable

Service charge: 10% of the transaction price

  • 设备品牌:赛多利斯(Sartorius)
  • 设备安装时间:2021/5/25
  • 设备所在地:国内
  • 设备型号:STR 200L
  • 设备序列号:4142100147/4142100148
  • 电压
  • 电频
  • 尺寸
  • 重量


Device built-in

Sartorius STR200L Single-Use Bioreactor - English Introduction

Product Overview
The Sartorius STR200L is a modular single-use bioreactor from the BIOSTAT® STR series, specifically designed for 200L-scale pilot and commercial production. Utilizing stirred-tank technology with Flexsafe® STR bags, it supports mammalian (e.g., CHO), insect cell, and microcarrier cultures, widely applied in mAb, vaccine, and gene therapy (e.g., AAV vector) manufacturing.

Core Technical Features

  1. Scalable Flexibility

    • 50-200L working volume with seamless scale-up from ambr® 15 to 2000L
    • Dual-pitched blade + Combi-sparger impeller ensures mixing efficiency and OTR up to 40h⁻¹ for high cell density cultures (e.g., MVCD 56E6 cells/mL)
    • Integrated load cells enable continuous perfusion via weight control, compatible with ATF6 cell retention systems
  2. Smart Process Control

    • BioPAT® sensors: ViaMass real-time viable cell density monitoring (<1% deviation) and Trace glucose/lactate analytics with feedback control
    • GMP-compliant data integrity for FDA/EMA filings
  3. Safety & Compliance

    • Pre-sterilized Flexsafe® STR bags (multi-layer PE film) prevent cross-contamination, featuring aseptic Opta/KPC connectors
    • Dual exhaust heating jackets and condensers minimize clogging risks in high-density cultures

Key Applications

  • Gene Therapy: Boosted production efficiency by 30% in China's first AAV drug "Xinjiuning 03"
  • mAb Production: Achieved >95% viability (Day 15) in 20-day perfusion cultures

Service Support
Includes process evaluation and demo units, with 3-year core component warranty.

(Note: Specifications based on Sartorius technical documents and user cases, updated 2025)

(Word count: 200 - Maintains all technical details including proprietary terms like "BioPAT®" and "Flexsafe®" while optimizing for conciseness in bioprocessing terminology.)


Email:newlife@yinzhisci.com

Tel:021-65381707